Our Pricing

Understanding Wegovy 1mg Dosing and UK Pricing

If you're researching wegovy 1mg price uk options, understanding the dosing schedule is essential before starting treatment. At Cured Pharmacy, Wegovy is available from £79.00 with transparent upfront pricing, free clinical consultation by UK prescribers, and discreet next-day delivery across the UK.

Can You Start Wegovy at 1mg?

No, you cannot start Wegovy treatment at the 1mg dose. The MHRA-approved prescribing protocol requires all patients to begin with a 0.25mg weekly dose for the first four weeks [1]. This gradual titration approach minimises gastrointestinal side effects whilst allowing your body to adapt to semaglutide.

The 1mg dose represents week 9 of your Wegovy journey, not the starting point. Clinical trials demonstrated that rapid dose escalation significantly increases discontinuation rates due to nausea and vomiting, which is why the structured four-week increments are medically necessary [1][2].

Your UK prescriber will assess your tolerance at each stage before authorising progression to higher doses. Skipping the initial titration phases is not clinically appropriate and would not be prescribed by any responsible healthcare professional in the UK.

Wegovy Dosing Schedule Explained

Some patients may require extended time at lower doses if they experience persistent side effects. Your prescriber can adjust the titration timeline based on your individual tolerance, though skipping doses or accelerating the schedule is not recommended [1].

The 1mg dose specifically serves as a mid-point assessment stage. By week 9, most patients report noticeable appetite reduction and early weight loss, which helps predict response to the full maintenance dose. If tolerability issues arise at 1mg, your prescriber may pause escalation or consider alternative treatments.

The Complete Titration Pathway

Wegovy follows a 16-week dose escalation schedule: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, then 2.4mg as the maintenance dose from week 17 onwards [1]. Each increment allows your body to adjust whilst progressively enhancing appetite suppression and metabolic effects.

In the STEP 1 trial, participants following this exact protocol achieved an average 14.9% body weight reduction over 68 weeks, compared to just 2.4% with placebo [2]. The gradual approach was crucial to these outcomes, with only 4.5% discontinuing due to gastrointestinal adverse events when proper titration was followed.

Wegovy 1mg Price UK and Treatment Costs

At Cured Pharmacy, Wegovy treatment starts from £79.00, with pricing remaining consistent throughout your titration journey regardless of dose strength. Unlike some providers who charge variable rates for different pen strengths, our transparent pricing model means you know your monthly cost from the outset.

The 1mg dose is supplied as part of the standard Wegovy pen system, with each pen containing four pre-filled doses. Your prescription will specify the appropriate pen strength for your current titration phase, and your UK prescriber will authorise progression based on your clinical response and tolerability.

All Wegovy prescriptions at Cured Pharmacy include a free clinical consultation with a UK-registered prescriber, discreet packaging, and next-day delivery across the UK. There are no hidden fees or consultation charges added at checkout, and you'll see the final price before completing your medical assessment.

How Wegovy 1mg Works in Your Body

By week 9 of treatment, when you reach the 1mg dose, most patients report substantial changes in hunger patterns and portion control. The medication doesn't create aversion to food; rather, it restores normal satiety signalling that may have been dysregulated in obesity [2][3].

At 1mg, you're receiving approximately 42% of the final maintenance dose strength. This intermediate level provides meaningful weight loss whilst allowing further dose optimisation. Research indicates that higher doses produce incrementally greater weight reduction, which is why progression to 2.4mg is recommended for most patients who tolerate the medication well [2].

Semaglutide's Mechanism of Action

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone your intestines produce after eating [3]. At the 1mg dose, semaglutide levels are sufficient to significantly slow gastric emptying, reduce appetite signals to the brain, and improve insulin sensitivity in peripheral tissues.

Clinical pharmacology studies show that semaglutide reaches steady-state concentrations after 4-5 weeks of consistent dosing [3]. This is why the 1mg phase lasts four weeks—it allows therapeutic levels to stabilise before progressing to higher doses, optimising both efficacy and tolerability.

Managing Side Effects at the 1mg Dose

Gastrointestinal side effects—particularly nausea, diarrhoea, and constipation—are most common during dose escalation periods, including the transition to 1mg [1][2]. In clinical trials, approximately 44% of participants reported nausea at some point during treatment, though most cases were mild to moderate and resolved within several weeks.

At the 1mg dose specifically, your body is adapting to a doubling of the previous 0.5mg strength. Practical strategies include eating smaller, more frequent meals, avoiding high-fat foods that delay gastric emptying further, and staying well-hydrated throughout the day. If nausea persists beyond two weeks at 1mg, contact your prescriber before your next scheduled dose increase.

Serious side effects are rare but require immediate medical attention. These include severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, vision changes, or signs of pancreatitis [1]. Your UK prescriber will review contraindications during your consultation, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Most patients who experience side effects at 1mg find they diminish significantly by week 11 or 12. The structured titration schedule exists precisely to minimise discontinuation due to tolerability issues whilst maximising the proportion of patients who reach the therapeutic 2.4mg maintenance dose.

Starting Your Wegovy Journey at Cured Pharmacy

Your first prescription will always be for the 0.25mg starting dose, regardless of previous weight loss medication experience. This non-negotiable clinical protocol protects patient safety and aligns with the licensed prescribing information approved by the MHRA [1].

Ongoing support is included throughout your treatment. As you progress through the titration schedule—including the 1mg phase at weeks 9-12—you can contact our clinical team with questions about side effects, dose progression, or lifestyle modifications that enhance results. Follow-up prescriptions are issued after clinical review confirms appropriate tolerance and response.

At Cured Pharmacy, we guarantee genuine UK-licensed Wegovy pens sourced directly from licensed wholesalers. Every medication is stored and dispensed according to GPhC standards, with full traceability and temperature-controlled logistics. You'll never receive grey-market or imported products from non-UK sources.

Our Clinical Assessment Process

Every Wegovy prescription begins with a free online consultation that takes under three minutes to complete. You'll provide your medical history, current medications, and weight management goals, which our UK-registered prescribers review to determine suitability for semaglutide treatment.

Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical services at Cured Pharmacy, ensuring every prescription meets MHRA guidelines and GPhC standards. If Wegovy is appropriate for you, your prescription is processed the same day, with medication dispatched in discreet packaging for next-day delivery across the UK.

Scientific References

1. Novo Nordisk. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Smits, M. M., & Van Raalte, D. H. (2021). Safety of Semaglutide. Frontiers in Endocrinology, 12, 645563. https://doi.org/10.3389/fendo.2021.645563

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.